What It Takes to Be Successful with GDUFA in 2021

GDUFA II was signed into law in 2017 effectively reauthorizing GDUFA I for fiscal years 2018 through 2022. The continuing goal of the amendment is to facilitate timely access to high-quality,...

7 Tips to Help You Prepare for Compliance in a Post COVID-19 World

Yes, there is a light at the end of the long, dark COVID-19 tunnel, and people’s lives will return to a state of normalcy. However, what will the new state of normalcy look like in a post COVID-19...

Meet the Expert: Robert Beall, PMP

ProPharma Group has launched a “Meet the Expert” series introducing you to our experts from around the world. This series will help you get to know who we are, and how our colleagues work to improve...

Meet the Expert: Daniel Wong

ProPharma Group has launched a “Meet the Expert” series introducing you to our experts from around the world. This series will help you get to know who we are, and how our colleagues work to improve...

Clinical Research Solutions

4 Common Bottlenecks to Avoid in the Development of Biopharmaceuticals

If you are involved in early development of biopharmaceuticals, have you ever experienced serious delays because of problems arising from tech transfer, from the first pilot scale batches not meeting...

A Roadmap to Authorization: Using Science to Prepare a MAA

As you move from Phase 3 clinical trials towards your Marketing Authorization Application (MAA), there are a number of critical steps that must be taken regarding how you interpret your clinical...

Unlocking Success with Clinical Trial Safety Monitoring During a Pandemic

Earlier this year I wrote to you about US FDA March 2020 issuance of a new guidance for industry, Investigators, and Institutional Review Boards regarding the conduct of clinical trials during the...

Meet the Expert: Matthew Weinberg

ProPharma Group has launched a “Meet the Expert” series introducing you to our experts from around the world. This series will help you get to know who we are, and how our colleagues work to improve...

Regulatory Sciences

10 Things You Need to Know about FDA’s Final Rule on Importing Prescription Drugs from Canada

Last week, FDA issued a final rule regarding the importation of certain prescription drugs from Canada. This action was taken by the agency as part of the Safe Important Action Plan, and was done in...

Clinical Research Solutions

Biosimilars: How the Approval Process Differs from a Standard ANDA

Biosimilars, by their very nature, are different from generic drugs. The core difference is that generic drugs are chemically synthesized, while biosimilars are grown in complex living systems....

505(b)(1) vs. 505(b)(2): Choosing the Appropriate Regulatory Pathway

Because the FDA is an agency established by a federal law, there are clearly defined pathways along which a drug can be approved. Deciding on the appropriate regulatory pathway for your drug...

6 Quick Tips for Excel Spreadsheet Validation

Are you using Microsoft Excel spreadsheets for GxP activities? Are these Excel sheets used again and again, as a template? Ever thought about validating your spreadsheet templates? Is the person who...

Meet the Expert: Dr. Borja López Pérez

ProPharma Group has launched a “Meet the Expert” series introducing you to our experts from around the world. This series will help you get to know who we are, and how our colleagues work to support...

Meet the Expert: Hannah Hunter

ProPharma Group has launched a “Meet the Expert” series introducing you to our experts from around the world. This series will help you get to know who we are, and how our colleagues work to support...

Just How Mature Is Your Data Lifecycle / Data Management Function?

The attention of regulatory agencies continues to focus on data integrity, as observed by the increase of FDA observations over the course of the last few years. Having a proper data lifecycle / data...

Clinical Research Solutions

Get the Most Out of Your GMP Effectiveness Checks

We work in a highly regulated industry. Whether you are associated with the manufacturing of a drug, a biologic, or a device, you understand the importance of those regulations on the safety and...